Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Peter Molloy has a successful track record of profitably recycling old drugs

Hikma Share News (HIK)

Stock Market news at - RSS News Feeds

Share News for Hikma (HIK)

Share Price: 1,074.00Bid: 1,074.00Ask: 1,075.00Change: 0.00 (0.00%)No Movement on Hikma
Spread: 1.00Spread as %: 0.09%Open: 1,056.00High: 1,087.00Low: 1,054.00Yesterday’s Close: 1,074.00

UPDATE 1-Britain's FTSE recoups early losses as cyclicals recover

* FTSE 100 up 0.1 pct, mid caps up 0.4 pct* Roche drug trial successes hit Shire shares* Mediclinic, Spire shares fall after takeover talks fall throu
[20 Nov '17 16:55]

UPDATE 1-Falls in Burberry, housebuilders pile pressure on FTSE

* FTSE 100 drops 0.6 pct, mid caps down 1.1 pct* Burberry plummets after new strategy, H1 results* Jitters around retailers confirmed with Sainsbury r
[9 Nov '17 17:04]

BUZZ-Top of the Street: Vinci, Caixabank, UDG, RSA

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:** JPMorgan raises Vinci to "overweight" on improvements over co
[9 Nov '17 11:25]

UPDATE 2-European shares suffer worst day since June as earnings underwhelm

* STOXX 600 down 1.1 pct, up 7.9 pct year-to-date* Siemens falls as results disappoint, warning hits Vestas* ECB supervisor lifts Italian banks, resul
[9 Nov '17 10:10]

Britain's FTSE under pressure as Burberry revamps its strategy

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)*
[9 Nov '17 10:10]

UPDATE 1-Hikma in dispute with FDA over generic Advair, cuts generics sales forecast again

(Adds shares, details, context)Nov 9 (Reuters) - Hikma Pharmaceuticals Plc is in dispute with the Food and Drug Administration over plans to launch a
[9 Nov '17 08:24]

Drugmaker Hikma cuts generics sales forecast a third time

Nov 9 (Reuters) - Hikma Pharmaceuticals Plc on Thursday lowered 2017 revenue guidance for its generics business for a third time.The Jordan-based firm
[9 Nov '17 07:48]

Hikma, Vectura in dispute with FDA over generic Advair

LONDON, Nov 9 (Reuters) - Hikma and its partner Vectura are in dispute with the Food and Drug Administration over their plans to launch a generic copy
[9 Nov '17 07:40]

Share Price, Share Chat, Stock Market news at
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.